Skip to main content
Top
Published in: Abdominal Radiology 12/2022

21-03-2022 | Computed Tomography | Special Section: Neuroendocrine Neoplasms

Small bowel neuroendocrine neoplasm: what surgeons want to know

Authors: Akshya Gupta, Meghan G. Lubner, Jason B. Liu, Elizabeth S. Richards, Perry J. Pickhardt

Published in: Abdominal Radiology | Issue 12/2022

Login to get access

Abstract

Neuroendocrine neoplasms of the small bowel are a diverse group of tumors with a broad spectrum of imaging findings and clinical implications. Most tumors originate in close proximity to the ileocecal valve and most commonly metastasize to the mesentery and liver. This review will highlight the imaging findings of primary and metastatic small bowel neuroendocrine neoplasm that are most relevant to the surgical team.

Graphical abstract

Literature
1.
go back to reference Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009; 249:63-71PubMedCrossRef Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009; 249:63-71PubMedCrossRef
2.
go back to reference Gonzalez RS. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms. Surg Pathol Clin 2020; 13:377-397PubMedCrossRef Gonzalez RS. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms. Surg Pathol Clin 2020; 13:377-397PubMedCrossRef
3.
go back to reference Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 2005; 19:675-697PubMedCrossRef Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 2005; 19:675-697PubMedCrossRef
4.
5.
go back to reference Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76:182-188PubMedCrossRef Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76:182-188PubMedCrossRef
6.
go back to reference Howe JR, Cardona K, Fraker DL, et al. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas 2017; 46:715-731PubMedPubMedCentralCrossRef Howe JR, Cardona K, Fraker DL, et al. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas 2017; 46:715-731PubMedPubMedCentralCrossRef
7.
go back to reference Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3063-3072CrossRef Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3063-3072CrossRef
8.
go back to reference Norlén O, Stålberg P, Öberg K, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg 2012; 36:1419-1431PubMedCrossRef Norlén O, Stålberg P, Öberg K, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg 2012; 36:1419-1431PubMedCrossRef
9.
go back to reference Landerholm K, Zar N, Andersson RE, Falkmer SE, Järhult J. Survival and prognostic factors in patients with small bowel carcinoid tumour. The British journal of surgery 2011; 98:1617-1624PubMedCrossRef Landerholm K, Zar N, Andersson RE, Falkmer SE, Järhult J. Survival and prognostic factors in patients with small bowel carcinoid tumour. The British journal of surgery 2011; 98:1617-1624PubMedCrossRef
10.
go back to reference Woltering EA, Voros BA, Beyer DT, et al. Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons 2017; 224:434-447PubMedCrossRef Woltering EA, Voros BA, Beyer DT, et al. Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons 2017; 224:434-447PubMedCrossRef
11.
go back to reference Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Annals of surgical oncology 2010; 17:3129-3136PubMedCrossRef Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Annals of surgical oncology 2010; 17:3129-3136PubMedCrossRef
12.
go back to reference Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery 2019; 165:644-651PubMedCrossRef Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery 2019; 165:644-651PubMedCrossRef
13.
14.
go back to reference Gupta A, Lubner MG, Wertz RM, Foley E, Loeffler A, Pickhardt PJ. CT detection of primary and metastatic ileal carcinoid tumor: rates of missed findings and associated delay in clinical diagnosis. Abdominal radiology (New York) 2019; 44:2721-2728CrossRef Gupta A, Lubner MG, Wertz RM, Foley E, Loeffler A, Pickhardt PJ. CT detection of primary and metastatic ileal carcinoid tumor: rates of missed findings and associated delay in clinical diagnosis. Abdominal radiology (New York) 2019; 44:2721-2728CrossRef
15.
go back to reference Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors. American journal of surgery 2004; 187:575-579PubMedCrossRef Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors. American journal of surgery 2004; 187:575-579PubMedCrossRef
16.
go back to reference Malla S, Kumar P, Madhusudhan KS. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review. Abdominal radiology (New York) 2021; 46:919-935CrossRef Malla S, Kumar P, Madhusudhan KS. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review. Abdominal radiology (New York) 2021; 46:919-935CrossRef
17.
go back to reference Levy AD, Sobin LH. Gastrointestinal Carcinoids: Imaging Features with Clinicopathologic Comparison. RadioGraphics 2007; 27:237-257PubMedCrossRef Levy AD, Sobin LH. Gastrointestinal Carcinoids: Imaging Features with Clinicopathologic Comparison. RadioGraphics 2007; 27:237-257PubMedCrossRef
18.
go back to reference Scott AT, Howe JR. Management of Small Bowel Neuroendocrine Tumors. Surg Oncol Clin N Am 2020; 29:223-241PubMedCrossRef Scott AT, Howe JR. Management of Small Bowel Neuroendocrine Tumors. Surg Oncol Clin N Am 2020; 29:223-241PubMedCrossRef
19.
go back to reference Modlin IMP, Oberg KP, Chung DCMD, et al. Gastroenteropancreatic neuroendocrine tumours. The lancet oncology 2008; 9:61-72PubMedCrossRef Modlin IMP, Oberg KP, Chung DCMD, et al. Gastroenteropancreatic neuroendocrine tumours. The lancet oncology 2008; 9:61-72PubMedCrossRef
20.
go back to reference Wolin EM, Benson Iii AB. Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review. Oncology 2019; 96:273-289PubMedCrossRef Wolin EM, Benson Iii AB. Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review. Oncology 2019; 96:273-289PubMedCrossRef
21.
go back to reference Di Giacinto P, Rota F, Rizza L, et al. Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors. International Journal of Endocrinology 2018; 2018:8126087PubMedPubMedCentralCrossRef Di Giacinto P, Rota F, Rizza L, et al. Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors. International Journal of Endocrinology 2018; 2018:8126087PubMedPubMedCentralCrossRef
22.
go back to reference Yang X, Yang Y, Li Z, et al. Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis. PLoS One 2015; 10:e0124884PubMedPubMedCentralCrossRef Yang X, Yang Y, Li Z, et al. Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis. PLoS One 2015; 10:e0124884PubMedPubMedCentralCrossRef
23.
go back to reference Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002; 39:577-582PubMedCrossRef Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002; 39:577-582PubMedCrossRef
24.
go back to reference Lawrence EM, Pickhardt PJ. Water-Soluble Contrast Challenge for Suspected Small-Bowel Obstruction: Technical Success Rate, Accuracy, and Clinical Outcomes. AJR American journal of roentgenology 2021; 217:1365-1366PubMedCrossRef Lawrence EM, Pickhardt PJ. Water-Soluble Contrast Challenge for Suspected Small-Bowel Obstruction: Technical Success Rate, Accuracy, and Clinical Outcomes. AJR American journal of roentgenology 2021; 217:1365-1366PubMedCrossRef
25.
go back to reference Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. The Radiologic clinics of North America 2021; 59:789-799PubMedCrossRef Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. The Radiologic clinics of North America 2021; 59:789-799PubMedCrossRef
26.
go back to reference Ganeshan D, Bhosale P, Yang T, Kundra V. Imaging Features of Carcinoid Tumors of the Gastrointestinal Tract. American Journal of Roentgenology 2013; 201:773-786PubMedCrossRef Ganeshan D, Bhosale P, Yang T, Kundra V. Imaging Features of Carcinoid Tumors of the Gastrointestinal Tract. American Journal of Roentgenology 2013; 201:773-786PubMedCrossRef
27.
go back to reference Galgano SJ, Sharbidre K, Morgan DE. Multimodality Imaging of Neuroendocrine Tumors. Radiologic clinics of North America 2020; 58:1147-1159PubMedCrossRef Galgano SJ, Sharbidre K, Morgan DE. Multimodality Imaging of Neuroendocrine Tumors. Radiologic clinics of North America 2020; 58:1147-1159PubMedCrossRef
28.
go back to reference Bonekamp D, Raman SP, Horton KM, Fishman EK. Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors. World journal of radiology 2015; 7:220-235PubMedPubMedCentralCrossRef Bonekamp D, Raman SP, Horton KM, Fishman EK. Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors. World journal of radiology 2015; 7:220-235PubMedPubMedCentralCrossRef
29.
go back to reference Hakim FA, Alexander JA, Huprich JE, Grover M, Enders FT. CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Digestive diseases and sciences 2011; 56:2914-2919PubMedCrossRef Hakim FA, Alexander JA, Huprich JE, Grover M, Enders FT. CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Digestive diseases and sciences 2011; 56:2914-2919PubMedCrossRef
30.
go back to reference Paulsen SR, Huprich JE, Fletcher JG, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006; 26:641-657; discussion 657-662PubMedCrossRef Paulsen SR, Huprich JE, Fletcher JG, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006; 26:641-657; discussion 657-662PubMedCrossRef
31.
go back to reference Kim S, Marcus R, Wells ML, et al. The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study. Abdominal radiology (New York) 2020; 45:623-631CrossRef Kim S, Marcus R, Wells ML, et al. The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study. Abdominal radiology (New York) 2020; 45:623-631CrossRef
32.
go back to reference Huprich JE, Fletcher JG, Fidler JL, et al. Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology 2011; 260:744-751PubMedCrossRef Huprich JE, Fletcher JG, Fidler JL, et al. Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology 2011; 260:744-751PubMedCrossRef
33.
go back to reference Manguso N, Gangi A, Johnson J, et al. The role of pre-operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary? Journal of surgical oncology 2018; 117:207-212PubMedCrossRef Manguso N, Gangi A, Johnson J, et al. The role of pre-operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary? Journal of surgical oncology 2018; 117:207-212PubMedCrossRef
34.
go back to reference Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. Journal of magnetic resonance imaging : JMRI 2001; 14:261-269PubMedCrossRef Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. Journal of magnetic resonance imaging : JMRI 2001; 14:261-269PubMedCrossRef
35.
go back to reference Dohan A, El Fattach H, Barat M, et al. Neuroendocrine tumors of the small bowel: evaluation with MR-enterography. Clinical imaging 2016; 40:541-547PubMedCrossRef Dohan A, El Fattach H, Barat M, et al. Neuroendocrine tumors of the small bowel: evaluation with MR-enterography. Clinical imaging 2016; 40:541-547PubMedCrossRef
36.
go back to reference Bodei L, Ambrosini V, Herrmann K, Modlin I. Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017; 58:1718-1726CrossRef Bodei L, Ambrosini V, Herrmann K, Modlin I. Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017; 58:1718-1726CrossRef
37.
go back to reference Yao JC, Hassan M, Phan A, et al. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology 2008; 26:3063-3072PubMedCrossRef Yao JC, Hassan M, Phan A, et al. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology 2008; 26:3063-3072PubMedCrossRef
38.
go back to reference Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G. Management of neuroendocrine tumors of unknown primary. Rev Endocr Metab Disord 2017; 18:423-431PubMedCrossRef Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G. Management of neuroendocrine tumors of unknown primary. Rev Endocr Metab Disord 2017; 18:423-431PubMedCrossRef
39.
go back to reference Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. European journal of nuclear medicine and molecular imaging 2010; 37:67-77PubMedCrossRef Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. European journal of nuclear medicine and molecular imaging 2010; 37:67-77PubMedCrossRef
40.
go back to reference Sanli Y, Garg I, Kandathil A, et al. Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT. American Journal of Roentgenology 2018; 211:267-277PubMedCrossRef Sanli Y, Garg I, Kandathil A, et al. Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT. American Journal of Roentgenology 2018; 211:267-277PubMedCrossRef
41.
go back to reference Clark M, Nathan M, Broski SM. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET. Clinical nuclear medicine 2019; 44:e308-e310PubMedCrossRef Clark M, Nathan M, Broski SM. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET. Clinical nuclear medicine 2019; 44:e308-e310PubMedCrossRef
42.
go back to reference Negoi I, Paun S, Hostiuc S, et al. Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo, Brazil) 2015; 13:500-505CrossRef Negoi I, Paun S, Hostiuc S, et al. Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo, Brazil) 2015; 13:500-505CrossRef
43.
go back to reference Gupta A, Lubner MG, Menias CO, Mellnick VM, Elsayes KM, Pickhardt PJ. Multimodality Imaging of Ileal Neuroendocrine (Carcinoid) Tumor. American Journal of Roentgenology 2019; 213:45-53PubMedCrossRef Gupta A, Lubner MG, Menias CO, Mellnick VM, Elsayes KM, Pickhardt PJ. Multimodality Imaging of Ileal Neuroendocrine (Carcinoid) Tumor. American Journal of Roentgenology 2019; 213:45-53PubMedCrossRef
44.
go back to reference Hellman P, Lundström T, Öhrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World Journal of Surgery 2002; 26:991-997PubMedCrossRef Hellman P, Lundström T, Öhrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World Journal of Surgery 2002; 26:991-997PubMedCrossRef
45.
go back to reference Le Roux C, Lombard-Bohas C, Delmas C, et al. Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study. Digestive and Liver Disease 2011; 43:828-833PubMedCrossRef Le Roux C, Lombard-Bohas C, Delmas C, et al. Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study. Digestive and Liver Disease 2011; 43:828-833PubMedCrossRef
46.
go back to reference Partelli S, Bartsch DK, Capdevila J, et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology 2017; 105:255-265PubMedCrossRef Partelli S, Bartsch DK, Capdevila J, et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology 2017; 105:255-265PubMedCrossRef
47.
go back to reference Walsh JC, Schaeffer DF, Kirsch R, et al. Ileal "carcinoid" tumors-small size belies deadly intent: high rate of nodal metastasis in tumors </=1 cm in size. Human pathology 2016; 56:123-127PubMedCrossRef Walsh JC, Schaeffer DF, Kirsch R, et al. Ileal "carcinoid" tumors-small size belies deadly intent: high rate of nodal metastasis in tumors </=1 cm in size. Human pathology 2016; 56:123-127PubMedCrossRef
48.
49.
go back to reference Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL. Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR American journal of roentgenology 1995; 164:387-391PubMedCrossRef Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL. Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR American journal of roentgenology 1995; 164:387-391PubMedCrossRef
50.
go back to reference Albanus DR, Apitzsch J, Erdem Z, et al. Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET). European journal of radiology 2015; 84:1866-1872PubMedCrossRef Albanus DR, Apitzsch J, Erdem Z, et al. Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET). European journal of radiology 2015; 84:1866-1872PubMedCrossRef
51.
go back to reference Hallet J, Law C. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors. World J Surg 2021; 45:197-202PubMedCrossRef Hallet J, Law C. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors. World J Surg 2021; 45:197-202PubMedCrossRef
52.
go back to reference Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R. Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. J Clin Med 2020; 9PubMedCentralCrossRef Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R. Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. J Clin Med 2020; 9PubMedCentralCrossRef
53.
go back to reference Ohrvall U, Eriksson B, Juhlin C, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 2000; 24:1402-1408PubMedCrossRef Ohrvall U, Eriksson B, Juhlin C, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 2000; 24:1402-1408PubMedCrossRef
54.
go back to reference Pasquer A, Walter T, Milot L, Hervieu V, Poncet G. Principles of Surgical Management of Small Intestinal NET. Cancers (Basel) 2021; 13CrossRef Pasquer A, Walter T, Milot L, Hervieu V, Poncet G. Principles of Surgical Management of Small Intestinal NET. Cancers (Basel) 2021; 13CrossRef
55.
go back to reference Clift AK, Faiz O, Al-Nahhas A, et al. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours. J Gastrointest Surg 2016; 20:180-188; discussion 188PubMedCrossRef Clift AK, Faiz O, Al-Nahhas A, et al. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours. J Gastrointest Surg 2016; 20:180-188; discussion 188PubMedCrossRef
56.
go back to reference d’Assignies G, Fina P, Bruno O, et al. High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging. Radiology 2013; 268:390-399PubMedCrossRef d’Assignies G, Fina P, Bruno O, et al. High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging. Radiology 2013; 268:390-399PubMedCrossRef
57.
go back to reference Norlén O, Edfeldt K, Akerstrom G, et al. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling. Surgery 2014; 156:1512-1521; discussion 1521-1512PubMedCrossRef Norlén O, Edfeldt K, Akerstrom G, et al. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling. Surgery 2014; 156:1512-1521; discussion 1521-1512PubMedCrossRef
58.
go back to reference Deleval N, Pesque L, Dieudonné A, et al. Prognostic impact of bone metastases detected by (18)F-DOPA PET in patients with metastatic midgut neuroendocrine tumors. European radiology 2021; 31:4166-4174PubMedCrossRef Deleval N, Pesque L, Dieudonné A, et al. Prognostic impact of bone metastases detected by (18)F-DOPA PET in patients with metastatic midgut neuroendocrine tumors. European radiology 2021; 31:4166-4174PubMedCrossRef
59.
go back to reference Scharf M, Petry V, Daniel H, Rinke A, Gress TM. Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. Neuroendocrinology 2018; 106:30-37PubMedCrossRef Scharf M, Petry V, Daniel H, Rinke A, Gress TM. Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. Neuroendocrinology 2018; 106:30-37PubMedCrossRef
60.
go back to reference Daskalakis K, Tsoli M, Srirajaskanthan R, et al. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance. Neuroendocrinology 2019; 108:308-316PubMedCrossRef Daskalakis K, Tsoli M, Srirajaskanthan R, et al. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance. Neuroendocrinology 2019; 108:308-316PubMedCrossRef
61.
go back to reference Sadowski SM, Neychev V, Millo C, et al. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; 34:588-596CrossRef Sadowski SM, Neychev V, Millo C, et al. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; 34:588-596CrossRef
62.
go back to reference Galgano SJ, Iravani A, Bodei L, El-Haddad G, Hofman MS, Kong G. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response—AJR Expert Panel Narrative Review. American Journal of Roentgenology 2022;CrossRefPubMed Galgano SJ, Iravani A, Bodei L, El-Haddad G, Hofman MS, Kong G. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response—AJR Expert Panel Narrative Review. American Journal of Roentgenology 2022;CrossRefPubMed
Metadata
Title
Small bowel neuroendocrine neoplasm: what surgeons want to know
Authors
Akshya Gupta
Meghan G. Lubner
Jason B. Liu
Elizabeth S. Richards
Perry J. Pickhardt
Publication date
21-03-2022
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2022
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-022-03485-6

Other articles of this Issue 12/2022

Abdominal Radiology 12/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare